Cancer risk assessment in modern radiotherapy workflow with medical big data

Fu Jin, Huan-Li Luo, Juan Zhou, Ya-Nan He, Xian-Feng Liu, Ming-Song Zhong, Han Yang, Chao Li, Qi-Cheng Li, Xia Huang, Xiu-Mei Tian, Da Qiu, Guang-Lei He, Li Yin, Ying Wang
  • Cancer Management and Research, June 2018, Dove Medical Press
  • DOI: 10.2147/cmar.s164980

Cancer risks in radiotherapy workflow

What is it about?

The exact mechanism and dose–response relationship for radiation-induced malignancy are not well understood. In this review, we develop risk assessments based on our current knowledge of IGRT and provide strategies for cancer risk reduction.

Why is it important?

Modern risk-based analysis shows that many errors that occur in radiation oncology are due to failures in workflow. These errors can lead to imbalance between benefits and risks.

Perspectives

Fu Jin (Author)

The cancer risk in modern RT workflow continues to be a problem.

open access logoRead Publication

http://dx.doi.org/10.2147/cmar.s164980

The following have contributed to this page: Fu Jin

In partnership with:

Authors